(Q38929364)

7 September 2017

title

The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway (English)

1 reference

7 September 2017

1 reference

L Wang

1

1 reference

7 September 2017

G Song

2

1 reference

7 September 2017

X Chang

3

1 reference

7 September 2017

W Tan

4

1 reference

7 September 2017

J Pan

5

1 reference

7 September 2017

X Zhu

6

1 reference

7 September 2017

Z Liu

7

1 reference

7 September 2017

M Qi

8

1 reference

7 September 2017

J Yu

9

1 reference

7 September 2017

B Han

10

1 reference

7 September 2017

language of work or name

English

0 references

publication date

15 December 2014

1 reference

7 September 2017

1 reference

7 September 2017

volume

34

1 reference

7 September 2017

issue

36

1 reference

7 September 2017

page(s)

4735-4745

1 reference

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Mechanisms of androgen receptor activation in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Castration-resistant prostate cancer: adaptive responses in the androgen axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Thioredoxin and protein kinases in redox signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Structure of the third catalytic domain of the protein disulfide isomerase ERp46

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Global analysis of differentially expressed genes in androgen-independent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Role of signaling transduction pathways in development of castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Enzalutamide for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Recent advances in Hsp90 inhibitors as antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

The influence of TXNDC5 gene on gastric cancer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Targeting HSP70 for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Chaperone heat shock protein 70 in nucleus accumbens core: a novel biological target of behavioural sensitization to morphine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Thioredoxin and related molecules--from biology to health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Multiple molecular chaperones interact with apolipoprotein B during its maturation. The network of endoplasmic reticulum-resident chaperones (ERp72, GRP94, calreticulin, and BiP) interacts with apolipoprotein b regardless of its lipidation state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Castration-resistant prostate cancer: targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

The role of hypoxia-inducible factor 1α in determining the properties of castrate-resistant prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Hypoxia enhances transcriptional activity of androgen receptor through hypoxia-inducible factor-1α in a low androgen environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Expression of Peptidylarginine Deiminase Type 4 in Ovarian Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

A novel proteomic coculture model of prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

CRL4B catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to promote tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

[EAU guidelines for prostate cancer: to screen or not to screen?]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Overexpression of thioredoxin system proteins predicts poor prognosis in patients with squamous cell carcinoma of the tongue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.401

Overexpression of the TXNDC5 protein in non-small cell lung carcinoma.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25500540

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2014.401

1 reference

Dimensions Publication ID

7 September 2017

1007847899

0 references

1 reference